Circovac® Delivers Clear Economic Gain

UK - An economic gain of around 33.33 per pig can result from vaccinating piglets with Circovac according to research presented by Merial at the European Symposium of Porcine Health Management (ESPHM) in May 2013 in Edinburgh.
calendar icon 1 May 2014
clock icon 2 minute read

The study presented by Dr Thais Vila, Merial Animal Health Swine Technical Director, was conducted on two Spanish farms and involved a total of 1239 piglets. Of these, 619 were vaccinated with Circovac® at weaning, while a further 620 were injected with a placebo. Depending on the site piglets were weighed at 168 or 189 days.

The gain per carcass (GPC) for pigs vaccinated with Circovac® was £2.12 on the first farm and £3.60 on the second. A simulation study showed an average expectation of £3.50 and £3.26 GPC respectively. The gain due to homogenization of the bodyweights was estimated to a 24p-27p GPC and could reach £1.22. Under the conditions of the study, a clear economic gain of approximately £3.28 per pig could be expected following Circovac vaccination in piglets.

Findlay MacBean, Merial Animal Health’s Head of Large Animal Business, said: “We are building a body of evidence to support the proposition that Circovac® is an excellent choice for piglet vaccination. This research further boosts the credentials of Circovac® as a piglet vaccine by clearly demonstrating its ability to boost producers’ profitability.”

© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.